Mouse study identifies bile acid pathways that may reduce liver fat

Nonalcoholic fatty liver disease (NAFLD), now known as metabolic dysfunction-associated steatotic liver disease (MASLD), is a common condition that causes excess fat to build up in the liver, affecting about one-quarter of adults worldwide. In some people, this can lead to inflammation and hepatocyte injury, triggering the formation of thick, fibrous connective tissue known as fibrosis.

≈